Featured Research

from universities, journals, and other organizations

Stopping liver failure from common painkiller overdose

Date:
February 4, 2014
Source:
University of Adelaide
Summary:
Researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller acetaminophen (also known as paracetamol).

University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen).

Published today in the Proceedings of the National Academy of Sciences (PNAS), the study pinpoints a target for new treatments to prevent the potentially lethal consequences of paracetamol overdose.

"Paracetamol is the most frequently used over-the-counter pain medication," says Dr Grigori Rychkov, Senior Research Fellow in the University's School of Medical Sciences.

"Overdose of paracetamol is the most common cause of acute liver failure and the leading cause of liver damage requiring transplantation in developed countries. The precise mechanisms of liver toxicity due to paracetamol overdose, however, have remained unclear."

It has been known for a long time that paracetamol overdose is associated with toxic levels of calcium in liver cells but nobody has known how the calcium gets into the cells.

The University of Adelaide researchers have identified a channel transporting calcium across the cell membrane that is triggered by paracetamol overdose, known as Transient Receptor Potential Melanostatine2 (TRPM2). Once the channel is activated, the cells become overloaded with calcium, leading to cell death. If this continues and enough cells die, it can lead to liver failure.

The research, conducted by PhD student Ehsan Kheradpezhouh, showed in laboratory studies that when the TRPM2 channel was missing or blocked, liver cells were protected from paracetamol damage.

"We now have a potential drug target for treating paracetamol overdose and possibly some other liver-damaging poisonings," says Dr Rychkov.

Currently paracetamol overdose can be effectively treated -- but only if caught within 18 hours.

"If we can block the TRPM2 channel we might be able to prevent the toxicity or extend this timeframe. If we can stop the calcium uptake and cell death, we'll be giving the liver a better chance for recovery and, hopefully, preventing complete liver failure," says Dr Rychkov.


Story Source:

The above story is based on materials provided by University of Adelaide. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Kheradpezhouh, L. Ma, A. Morphett, G. J. Barritt, G. Y. Rychkov. TRPM2 channels mediate acetaminophen-induced liver damage. Proceedings of the National Academy of Sciences, 2014; DOI: 10.1073/pnas.1322657111

Cite This Page:

University of Adelaide. "Stopping liver failure from common painkiller overdose." ScienceDaily. ScienceDaily, 4 February 2014. <www.sciencedaily.com/releases/2014/02/140204101416.htm>.
University of Adelaide. (2014, February 4). Stopping liver failure from common painkiller overdose. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140204101416.htm
University of Adelaide. "Stopping liver failure from common painkiller overdose." ScienceDaily. www.sciencedaily.com/releases/2014/02/140204101416.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins